Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation

Transplantation

Volumn 73, Issue 9, 2002, Pages 1403-1410

  Nomura, Masaru ^a   Yamashita, Kenichiro ^a   Murakami, Masaaki ^a   Takehara, Megumi ^a   Echizenya, Hayato ^a   Sunahara, Masao ^a   Kitagawa, Norihiko ^a   Fujita, Miri ^a   Furukawa, Hiroyuki ^a   Uede, Toshimistu ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD40 ANTIGEN; CD40 IMMUNOGLOBULIN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOGLOBULIN GENE; IMMUNOSUPPRESSIVE TREATMENT; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; MONONUCLEAR CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; SKIN GRAFT; TRANSPLANTATION TOLERANCE; VIRAL GENE THERAPY;

EID: 0037093518     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200205150-00008     Document Type: Article

References (55)

1. A cell culture model for T lymphocyte clonal anergy
2. Transplant tolerance induced by CTLA4-Ig
3. CD40-gp39 interactions play a critical role during allograft rejection
4. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand
5. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
6. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
7. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
8. CTLA4-Ig and antiCD40 ligand prevent renal allograft rejection in primates
9. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in non human primates
10. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys with humanized anti-CD154
11. Prolongation of primate cardiac allograft, survivals by treatment with anti-CD40 ligand (CD154) antibody
12. Thromboembolic complication after treatment with monoclonal antibody against CD40 ligand
13. Preliminary results of the use of humanized anti-CD154 in human renal allotransplantation
14. Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG
15. Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and Lox P
16. Genomic structure and chromosomal mapping of murine CD40 gene
17. Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage
18. The CD40 antigen and its ligand
19. + T cell immunity
20. CD40 and CD154 in cell-mediated immunity
21. Expansion or elimination of B cells in vivo
22. The many roles of CD40: CD40 interaction in cell mediated inflammatory responses
23. Impairment of antigen specific T-cell priming in mice lacking CD40 ligand
24. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
25. CD40 ligand dependent T cell activation; Requirement of B7-CD28 signaling through CD40
26. A new mechanism of NK cell cytotoxicity activation: The CD-CD40L mediated signals
27. CD40 ligand gene defects responsible for X-linked Hyper-IgM syndrome
28. Soluble forms of CD40 inhibit biologic responses of human B cells
29. Adenovirus-mediated gene transfer in the transplant setting: Early events after orthotopic liver transplantation of liver allografts expressing TGF-beta1
30. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival
31. Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation
32. Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival
33. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
34. Adenovirus-mediated gene therapy to liver grafts: Successful gene transfer by donor pretreatment
35. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver
36. MHC class 1-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with Eldeleted recombinant adenoviruses
37. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
38. Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response
39. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduces into liver using recombinant adenoviruses in the rat
40. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissue
41. Gene therapy death prompts review of adenovirus vector
42. Liver-directed gene transfer in nonhuman primates
43. Adenovirus-mediated gene transfer in the transplant setting: Variables affecting gene transfer in liver grafts
44. Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains
45. Requirement for T cell apoptosis in the induction of peripheral transplantation
46. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
47. + T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
48. Murine liver allograft transplantation: Tolerance and donor cell chimerism
49. Fully allogenic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens
50. Induction of immunological tolerance by porcine liver allografts
51. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody
52. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats
53. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance
54. Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes
55. Evidence of alloreactive T suppressor cells in the maintenance phase of spontaneous tolerance after orthotopic liver transplantation in the rat